Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amylyx Pharmaceuticals, Inc. - Common Stock
(NQ:
AMLX
)
1.755
-0.135 (-7.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amylyx Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
FDA Panel Votes Down For Amylyx's ALS Drug, Further Fading Its Hope For Regulatory Success
March 31, 2022
An advisory committee of the
Via
Benzinga
Amylyx Pharmaceuticals Reports Full Year 2021 Financial Results
March 30, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals Announces Outcome of FDA Advisory Committee Meeting on AMX0035 for the Treatment of ALS
March 30, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharma Stock Hinges On This FDA Action — Here's What To Know
March 30, 2022
Amylyx is facing an FDA advisory committee Wednesday that will vote on its ALS drug.
Via
Investor's Business Daily
The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict
March 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Amylyx Shares Plummet On Skeptical FDA Adcomm Docs On ALS Drug
March 28, 2022
Via
Benzinga
Amylyx Pharmaceuticals Stock Trading Halted Today
March 30, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
50 Biggest Movers From Yesterday
March 29, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...
Via
Benzinga
Mid-Day Market Update: Crude Oil Dips 8%; Plantronics Shares Spike Higher
March 28, 2022
U.S. stocks traded mixed midway through trading, with the Dow dropping 175 points on Monday.
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
March 28, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....
Via
Benzinga
Amylyx Pharmaceuticals Stock Crashes As FDA Doubts Its ALS Treatment
March 28, 2022
Amylyx Pharmaceuticals could face an uphill battle for its ALS treatment this week.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on AMX0035
March 28, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Monday
March 28, 2022
On Monday, 147 stocks hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Mid-Morning Market Update: Markets Mixed; SAIC Profit Tops Views
March 28, 2022
U.S. stocks traded mixed this morning, with the Dow dropping around 100 points on Monday.
Via
Benzinga
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Via
Benzinga
Opening Day: AN2 Therapeutics Rises In Public Debut After Upsized IPO
March 26, 2022
Shares of AN2 Therapeutics rose over 15% in its trading debut on Friday following an upsized initial public offering. This was only the second initial public offering this month, as the IPO market...
Via
Talk Markets
IPO Stock Amylyx Pharmaceuticals Broke Down — But Just Wait For Its Encore
March 25, 2022
Here's why a former breakdown stock, Amylyx, has run up for two consecutive days.
Via
Investor's Business Daily
Amylyx Pharmaceuticals Announces Launch of U.S. Expanded Access Program for AMX0035
March 18, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
7 Biotech Stocks With Key Catalysts in March
March 09, 2022
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.
Via
InvestorPlace
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
March 02, 2022
The Food and Drug Administration approval calendar was light in February. Nevertheless, the month saw regulatory nods accorded to some breakthrough therapies. Agios...
Via
Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
Gainers Avenue Therapeutics, Inc. (NASDAQ: ATXI) jumped 78.5% to close at $0.6066 on Tuesday after jumping 36% on Monday. CTI BioPharma Corp. (NASDAQ: CTIC) surged 63...
Via
Benzinga
Amylyx Pharmaceuticals Announces EMA Validation of Marketing Authorisation Application (MAA) for AMX0035 for the Treatment of ALS
February 25, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals Expands Executive Team with Appointment of Gina M. Mazzariello as Chief Legal Officer and General Counsel
February 23, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
73 Biggest Movers From Yesterday
February 23, 2022
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...
Via
Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
February 22, 2022
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...
Via
Benzinga
FDA Sets Up Adcomm To Review Amylyx's ALS Drug Next Month
February 17, 2022
The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will review Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) marketing application for...
Via
Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...
Via
Benzinga
70 Biggest Movers From Friday
February 22, 2022
Gainers Sky Harbour Group Corporation (NYSE: SKYH) shares jumped 48.4% to close at $10.09 on Friday. RISE Education Cayman Ltd (NASDAQ: REDU) gained 39.7% to settle at $0.95....
Via
Benzinga
Amylyx Pharmaceuticals Announces FDA Advisory Committee Meeting to Review New Drug Application for AMX0035 for the Treatment of ALS Scheduled for March 30, 2022
February 16, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
Amylyx Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare Conference
February 10, 2022
From
Amylyx Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.